fintols

Procter & Gamble (PG): analysis in plain words

Is Procter & Gamble cheap or expensive? How it makes money, whether it grows and its risks, explained in plain words and with its official accounts.

Procter & Gamble (PG) is listed on the NYSE and we classify it in consumer staples. Below are its key dated figures, how it makes money, how it compares with its sector, what works for and against Procter & Gamble according to those figures, and the questions people ask most about the stock. No buy or sell tips.

Procter & Gamble (PG) key figures as of November 4, 2026

FigureValueWhat it measures
Share price$167.32Last price on November 4, 2026
P/E ratio (TTM)25.2xPrice over earnings per share
Revenue growth+4.0%Latest quarter vs the same quarter a year earlier
Net margin (TTM)18.2%Profit for every 100 of sales
Net debt / EBITDA0.9xYears of operating profit to repay debt
Dividend yield2.69%Annual dividend over price
Market cap$387.8 billionWhat the stock market values it at

The Procter & Gamble figures come from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026. Any PG figure that is not available shows as N/A: we do not estimate it.

How Procter & Gamble makes money

Procter & Gamble reports five segments: Fabric & Home Care, the largest, with Tide, Ariel, Downy, Dawn and Febreze; Baby, Feminine & Family Care, with Pampers, Always, Charmin and Bounty; Beauty, with Pantene, Olay and Head & Shoulders; Health Care, with Crest, Oral-B and Vicks; and Grooming, with Gillette and Venus.

Over the last 12 months, Procter & Gamble brought in revenue of $87.9 billion. For every 100 it sells, Procter & Gamble keeps 50.6 after the direct cost of what it sells (gross margin) and 26.9 after all operating costs (operating margin).

Procter & Gamble against its sector

To know whether a Procter & Gamble figure is high or low you have to put it next to similar companies. This table compares Procter & Gamble with the median of the 17 consumer staples companies Fintols covers, with data as of November 4, 2026.

FigureProcter & Gambleconsumer staples median
P/E25.2x21.3x (17)
Revenue growth+4.0%+3.6% (19)
Net margin18.2%12.8% (19)
Dividend yield2.69%3.19% (19)
Net debt / EBITDA0.9x1.7x (19)

In short, against the typical consumer staples company, Procter & Gamble trades on a higher P/E, earns a wider margin and pays a lower dividend yield. By size, Procter & Gamble ranks number 2 of 13 consumer staples companies quoted in USD on Fintols.

The bull case for Procter & Gamble

These are the strengths in the Procter & Gamble figures as of November 4, 2026:

The main risk for Procter & Gamble

The Procter & Gamble figures as of November 4, 2026 show no clear red flag (no heavy debt, no losses, no falling sales). Its main risk is the one built into its business: customers switching to cheaper store brands and rising prices for the raw materials it buys.

Frequently asked questions about Procter & Gamble

Is it a good time to buy Procter & Gamble stock?

Fintols does not tell you whether to buy or sell Procter & Gamble, and nobody knows what the price will do tomorrow. What we can show you is where it stands today. As of November 4, 2026, Procter & Gamble stock trades at $167.32, 0% below its 52-week high ($168.16) and 22% above its low ($137.62). Its P/E is 25.2x against a consumer staples median of 21.3x, and 22.6x on the earnings analysts expect over the next 12 months. With Procter & Gamble, as with any stock, timing matters less than understanding the business, investing for the long run and not betting everything on a single company.

Does Procter & Gamble pay a dividend?

Yes. As of November 4, 2026, Procter & Gamble pays $4.35 per share a year, which at today's price is a yield of 2.69%. It uses 65% of its profit to pay it.

Is Procter & Gamble stock expensive?

It depends on what you compare it with. On P/E, Procter & Gamble trades at 25.2x its last 12 months of earnings: more expensive than the consumer staples median (21.3x). A high P/E alone does not make Procter & Gamble expensive: it can be justified if earnings grow fast, and a low one can reflect a business in trouble.

Who are Procter & Gamble's competitors?

On Fintols we compare Procter & Gamble with Coca-Cola, PepsiCo and Philip Morris, which are also in consumer staples. As of November 4, 2026, Coca-Cola is worth $412.1 billion and trades on a P/E of 28.6; PepsiCo is worth $194.1 billion and trades on a P/E of 17.9; Philip Morris is worth $329.3 billion and trades on a P/E of 30.8. Each has a side-by-side comparison with Procter & Gamble below.

Procter & Gamble competitors

To understand Procter & Gamble better

More companies like Procter & Gamble: consumer staples stocks, S&P 500 companies and S&P 100 companies. Open the full PG analysis with its valuation and scenarios. Educational content about Procter & Gamble, not investment advice.